semaglutide clinical trials What the SELECT trial of means for clinicians Two-year effects of semaglutide in

Most GLP-1 users experience temporary nausea and digestive changes that peak in the first 24 weeks, then gradually fade as the body adjusts

The combined action of these mechanisms results in improved glycemic control, weight loss, and potential cardiovascular benefits observed in clinical studies

If appetite is lower on a GLP-1, its still important to make sure your body is getting enough...

Its smart, its human, and its the kind of honest talk you wish existed in your doctors office.

Delivering immune stimulating antigens to specific areas of the gut, using proprietary encapsulation technologies, with the objective of activating protective mucosal immunity

These GLP-1 injections were originally designed to treat type 2 diabetes, but theyve quickly gained popularity as powerful tools for weight loss